Skip to main content
Premium Trial:

Request an Annual Quote

Eutillio Buccilli

Genetic Technologies appointed Eutillio Buccilli its CEO. Buccilli joined the company in June 2014 as CFO and later also took on the role of Genetic Technologies' COO. He has more than 35 years of senior management experience in the financial services, contracting and recruitment, property, and retail industries, including at General Electric, Computer Science, and Coles Myer. Genetic Technologies' former CEO Alison Mew resigned in December. 

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.